Close Menu

The industry trade group PhRMA has new clinical trial guidelines that take effect today, reports the Wall Street Journal Health Blog. The new rules discourage ghostwriting — "authors should identify individuals who provide writing or other assistance and disclose the funding source for this assistance" — and says that doctors who have a financial stake in a drug should not be involved in a clinical trial of that drug.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to the Associated Press, genetic genealogy has helped law enforcement officials identify an unknown victim of the Green River Killer.

Imperial College London researchers are shifting away from testing a COVID-19 vaccine to focus on combating newly emerging SARS-CoV-2 variants, the Independent says.

In PNAS this week: target to reduce chemotherapy-induced cardiac injury, tool finds ancient endogenous RNA viruses, and more.

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.